Five-year data from Phase III trials demonstrated that 67.7% of patients moderate-to-severe plaque psoriasis treated with UCB ...

Clinical trial results found that a majority of patients with atopic dermatitis who were treated with Ebgylss achieved ...

HEOR scientists in the pharma industry must balance methodologic rigor with commercial expectations and timelines.

Self-service data analytics company Gigasheet announced a new digital platform designed to enhance healthcare price ...

The approval of neffy marks the first major advancement in epinephrine delivery for patients over four years of age in more ...

Joint venture is expected to leverage Astellas' expertise in cell therapy R&D and Yaskawa’s robotics technology to enhance ...

The acquisition is expected to enhance Jazz's oncology portfolio by adding dordaviprone, a novel small molecule therapy in ...

In this Pharmaceutical Executive video interview, Jen Butler, Chief Commercial Officer for Pleio, explores what kind of role ...

The six key design trends of 2025 redefine how healthcare brands can inspire trust and build lasting connections with their ...

Ron Lanton, Partner, Lanton Law, discusses the legal and industry challenges posed by recent National Institute of Health budget cuts, diversity bans in clinical trials, and pharmaceutical supply ...

In this Pharmaceutical Executive Video Interview, Peter Ax, Founder & CEO of UpScriptHealth, describes how his company's ...

In this Pharmaceutical Executive Video Interview, Peter Ax, Founder & CEO of UpScriptHealth, explores how tariffs could ...